Clinical Trials · NCT03475758
Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Assiut University
- Enrollment
- 100
- Start date
- Mar 2018
- Locations
- See registry
- Primary endpoint
- compare rate of ovarian failure at 1 year between the two treatment groups